News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CombiMatrix Corporation (CBMX) Names Richard Hockett, M.D. Medical Director



4/11/2012 9:58:51 AM

IRVINE, Calif., April 11, 2012 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for cancer and developmental disorders, today announced that veteran molecular diagnostics specialist Richard Hockett, M.D. has been named Medical Director, effective May 1. Hockett, 52, will report directly to CombiMatrix CEO R. Judd Jessup.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES